Literature DB >> 16890836

HIV/AIDS epidemiology, pathogenesis, prevention, and treatment.

Viviana Simon1, David D Ho, Quarraisha Abdool Karim.   

Abstract

The HIV-1 pandemic is a complex mix of diverse epidemics within and between countries and regions of the world, and is undoubtedly the defining public-health crisis of our time. Research has deepened our understanding of how the virus replicates, manipulates, and hides in an infected person. Although our understanding of pathogenesis and transmission dynamics has become more nuanced and prevention options have expanded, a cure or protective vaccine remains elusive. Antiretroviral treatment has transformed AIDS from an inevitably fatal condition to a chronic, manageable disease in some settings. This transformation has yet to be realised in those parts of the world that continue to bear a disproportionate burden of new HIV-1 infections and are most affected by increasing morbidity and mortality. This Seminar provides an update on epidemiology, pathogenesis, treatment, and prevention interventions pertinent to HIV-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16890836      PMCID: PMC2913538          DOI: 10.1016/S0140-6736(06)69157-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  200 in total

1.  An anthropoid-specific locus of orphan C to U RNA-editing enzymes on chromosome 22.

Authors:  Adam Jarmuz; Ann Chester; Jayne Bayliss; Jane Gisbourne; Ian Dunham; James Scott; Naveenan Navaratnam
Journal:  Genomics       Date:  2002-03       Impact factor: 5.736

Review 2.  The role of sexually transmitted diseases in HIV transmission.

Authors:  Shannon R Galvin; Myron S Cohen
Journal:  Nat Rev Microbiol       Date:  2004-01       Impact factor: 60.633

3.  Prevention of mother-to-child transmission of HIV infection.

Authors:  Katherine Luzuriaga; John L Sullivan
Journal:  Clin Infect Dis       Date:  2005-01-07       Impact factor: 9.079

4.  Effectiveness and cost effectiveness of early and late prevention of HIV/AIDS progression with antiretrovirals or antibiotics in Southern African adults.

Authors:  M O Bachmann
Journal:  AIDS Care       Date:  2006-02

Review 5.  Inactivated- or killed-virus HIV/AIDS vaccines.

Authors:  Haynes W Sheppard
Journal:  Curr Drug Targets Infect Disord       Date:  2005-06

6.  Breast-milk shedding of drug-resistant HIV-1 subtype C in women exposed to single-dose nevirapine.

Authors:  Esther J Lee; Rami Kantor; Lynn Zijenah; Wayne Sheldon; Lynda Emel; Patrick Mateta; Elizabeth Johnston; Jennifer Wells; Avinash K Shetty; Hoosen Coovadia; Yvonne Maldonado; Samuel Adeniyi Jones; Lynne M Mofenson; Christopher H Contag; Mary Bassett; David A Katzenstein
Journal:  J Infect Dis       Date:  2005-08-23       Impact factor: 5.226

7.  Turnover rates of B cells, T cells, and NK cells in simian immunodeficiency virus-infected and uninfected rhesus macaques.

Authors:  Rob J De Boer; Hiroshi Mohri; David D Ho; Alan S Perelson
Journal:  J Immunol       Date:  2003-03-01       Impact factor: 5.422

8.  Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

Authors:  A Mocroft; S Vella; T L Benfield; A Chiesi; V Miller; P Gargalianos; A d'Arminio Monforte; I Yust; J N Bruun; A N Phillips; J D Lundgren
Journal:  Lancet       Date:  1998-11-28       Impact factor: 79.321

9.  Male circumcision and HIV control in Africa.

Authors:  Michel Garenne
Journal:  PLoS Med       Date:  2006-01-31       Impact factor: 11.069

10.  Ancient adaptive evolution of the primate antiviral DNA-editing enzyme APOBEC3G.

Authors:  Sara L Sawyer; Michael Emerman; Harmit S Malik
Journal:  PLoS Biol       Date:  2004-07-20       Impact factor: 8.029

View more
  126 in total

1.  Clinical Use of Inhibitors of HIV-1 Integration: Problems and Prospects.

Authors:  S P Korolev; Yu Yu Agapkina; M B Gottikh
Journal:  Acta Naturae       Date:  2011-07       Impact factor: 1.845

2.  EASY-HIT: HIV full-replication technology for broad discovery of multiple classes of HIV inhibitors.

Authors:  Stephan Kremb; Markus Helfer; Werner Heller; Dieter Hoffmann; Horst Wolff; Andrea Kleinschmidt; Sabine Cepok; Bernhard Hemmer; Jörg Durner; Ruth Brack-Werner
Journal:  Antimicrob Agents Chemother       Date:  2010-09-27       Impact factor: 5.191

3.  Anti-HIV-1 therapeutics: from FDA-approved drugs to hypothetical future targets.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Mol Interv       Date:  2009-04

4.  Male circumcision and prevention of HIV and sexually transmitted infections.

Authors:  Ronald H Gray; Maria J Wawer; Chelsea B Polis; Godfrey Kigozi; David Serwadda
Journal:  Curr Infect Dis Rep       Date:  2008-05       Impact factor: 3.725

Review 5.  Novel approaches to inhibiting HIV-1 replication.

Authors:  Catherine S Adamson; Eric O Freed
Journal:  Antiviral Res       Date:  2009-09-24       Impact factor: 5.970

6.  Spatial visualization of multivariate datasets: an analysis of STD and HIV/AIDS diagnosis rates and socioeconomic context using ring maps.

Authors:  Ana Lòpez-De Fede; John E Stewart; James W Hardin; Kathy Mayfield-Smith; Dawn Sudduth
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

7.  'Stuck in the quagmire of an HIV ghetto': the meaning of stigma in the lives of older black gay and bisexual men living with HIV in New York City.

Authors:  Rahwa Haile; Mark B Padilla; Edith A Parker
Journal:  Cult Health Sex       Date:  2011-04

8.  Association between living with children and adherence to highly active antiretroviral therapy in the Women's Interagency HIV Study.

Authors:  Daniel J Merenstein; Michael F Schneider; Christopher Cox; Rebecca Schwartz; Kathleen Weber; Esther Robison; Monica Gandhi; Jean Richardson; Michael W Plankey
Journal:  Pediatrics       Date:  2008-04       Impact factor: 7.124

9.  SAMMA, a mandelic acid condensation polymer, inhibits dendritic cell-mediated HIV transmission.

Authors:  Theresa L Chang; Natalia Teleshova; Aprille Rapista; Maciej Paluch; Robert A Anderson; Donald P Waller; Lourens J D Zaneveld; Angela Granelli-Piperno; Mary E Klotman
Journal:  FEBS Lett       Date:  2007-08-31       Impact factor: 4.124

10.  Current status of Japanese HIV-infected patients with coagulation disorders: coinfection with both HIV and HCV.

Authors:  Shinobu Tatsunami; Junichi Mimaya; Akira Shirahata; Jiří Zelinka; Ivana Horová; Jugo Hanai; Yutaka Nishina; Katsumi Ohira; Masashi Taki
Journal:  Int J Hematol       Date:  2008-08-02       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.